2022 News Release
-
Three Pharmaceutical Organizations of Japan, the U.S. and Europe: Joint Statement on the FY2023 NHI Drug Price Revision
-
The 16th Annual Survey on Consumer Awareness of Drugs and the Pharmaceutical Industry
-
Three Pharmaceutical Organizations: Joint Position on the Midyear Revision of NHI Drug Prices
-
Cabinet Decision on the Second Supplementary Budget for FY2022
-Toward Strengthening the Drug Discovery Venture Ecosystem in Japan -
Announcement of the Pharmaceutical Association of Japan Code of Practice "Month for Promoting Understanding of the Code
-
Greater Tokyo Biocommunity (GTB): Collaboration among the University of Tokyo, the Medical and Dental University, and the Pharmaceutical Cooperative Association in the Hongo, Ochanomizu, and Tokyo Station Area
-
Election of New Board Members
-
Material from the August 30 press conference by the Chairman of the Pharmaceutical Manufacturers Association of Japan (PMAJ)
-
Toward the Creation of an Ecosystem to Enhance Japan's Drug Discovery Capability
-
TRIPS Weber Agreement at the 12th WTO Ministerial Conference
-
Jointly produced and released by the Council for the Proper Use of Drugs and the Japan Pharmaceutical Manufacturers Association
Supervision: Professor Masahiro Akishita, University of Tokyo and Ministry of Health, Labor and Welfare
Educational video on polypharmacy "How Many of Your Drugs Are You Taking? -
Statement by the R&D-based pharmaceutical industry on the planned consultations on the exemption of intellectual property protection obligations at the 12th WTO Ministerial Conference
-
Proposal by Japan, U.S., Europe and the three pharmaceutical organizations: Joint Proposal for the Formulation of a "Framework Policy" and a "Growth Strategy
-
Discussion on the Exemption from the Obligation to Protect Intellectual Property in the WTO
-
The 11th Asian Pharmaceutical Association Conference (APAC) Press Conference held on April 6
-
The 11th Asian Pharmaceutical Association Conference (APAC)
-
Joint "Data Integrity Declaration" by the three organizations for clinical trials and clinical studies
-
Joint Statement on "Three Priorities to Increase Access to COVID-19 Vaccine as Soon as Possible
-
About the FY2021 Pharmaceutical Cooperative Communiqué Plan
-
Announcement of the launch of the official Twitter account of the Pharmaceutical Manufacturers Association of Japan (PMAJ)
-
Press Conference by the Chairman of the Pharmaceutical Manufacturers Association of Japan held on January 20
-
New Year's Greetings from the Chairman of the Pharmaceutical Manufacturers Association of Japan, 2022
